Ruthenium polypyridyl complexes with anticancer properties

The perfect anticancer drug would kill cancer cells without causing any harm to the surrounding healthy tissues. That ideal medicine is searched for in this thesis, in the form of a ruthenium coordination complex.Metal complexes are known to interact with DNA in several different modes, amongst which are coordination, intercalation of the aromatic part of the molecule between the DNA base-pairs and binding of the complex to one of the DNA grooves.Is there a correlation between the ruthenium–DNA interactions and the cytotoxicity of these complexes? Three ruthenium polypyridyl complexes (1a-c) were synthesized and characterized, which can coordinate to guanine. The structure-related 1e and 1f, as well as the dinuclear complex 1g, were also chosen for these studies. The interactions between each ruthenium complex and DNA were studied; the activities of the compounds in different cancer cells were tested.The results of these tests suggest that 1a-c and 1e coordinate to DNA, while 1g probably fits in the DNA groove. These complexes display moderate activity in some cancer cell lines. The inactive complex 1f can coordinate to guanine and bind to DNA via intercalation or groove-binding. 1f is the only one of the studied compounds that lacks an azo group, which suggests that this group is essential for cytotoxicity.The interactions between metal complexes and other biological molecules are also mentioned.